SOLENO THERAPEUTICS INC

SLNO

SLNO has 2 disclosed filings on Paydirt over the trailing twelve months from 2 corporate insiders: 0 purchases and 2 sales. Filers took a median of 4 days from execution to disclosure, and the most recent trade was executed Mar 27 and filed Mar 31. The most active filer was Patricia C Hirano with 4 filings.

Add to watchlist

Filings, ttm

0 buys · 2 sells

Traders, ttm

2 insiders

Volume, ttmiDollar value disclosed in the window

$274K

estimated for Congress, as filed for insiders

Median delay

execution to disclosure

Last traded

Mar 27

Filed Mar 31

ADViAverage daily dollar volume

–

not on file

No price series on file for SLNO yet.

Volume by month

Buys $0 Sells $202.8M

Estimated for Congress, as filed for insiders · by filing month · past 24 months

Who filed

PH Patricia C Hirano SEE REMARKS 4 filings BA Bhatnagar Anish CHIEF EXECUTIVE OFFICER 3 filings JM James H Mackaness CHIEF FINANCIAL OFFICER 3 filings KY Kristen Yen SEE REMARKS 3 filings MH Michael F. Huang Sr. VP of Clinical Development 2 filings MM Meredith Manning Chief Commercial Officer 2 filings MP Matthew Pauls Director 1 filing VP Vivo Opportunity Fund Holdings, L.P. 10% owner 1 filing

Recent filings

Michael F. HuangSALE Sr. VP of Clinical Development $128K
4,256 sh × $30.04
Exec Mar 27
Filed Mar 31 · 5:30 PM ET Meredith ManningSALE Chief Commercial Officer $146K
4,864 sh × $30.04
Exec Mar 27
Filed Mar 31 · 5:30 PM ET Patricia C HiranoSALE SEE REMARKS $317K
3,830 sh × $82.76
Exec Jul 1 2025
Filed Jul 3 2025 · 5:30 PM ET Patricia C HiranoSALE SEE REMARKS $265K
3,782 sh × $70.11
Exec Apr 1 2025
Filed Apr 2 2025 · 5:30 PM ET Bhatnagar AnishSALE CHIEF EXECUTIVE OFFICER $47.2M
698,363 sh across 11 lots
Exec Mar 27 2025
Filed Mar 31 2025 · 5:30 PM ET Patricia C HiranoSALE SEE REMARKS $10.6M
154,017 sh across 12 lots
Exec Mar 27 2025
Filed Mar 31 2025 · 5:30 PM ET Michael F. HuangSALE Sr. VP of Clinical Development $700K
10,000 sh × $70.03
Exec Mar 27 2025
Filed Mar 31 2025 · 5:30 PM ET James H MackanessSALE CHIEF FINANCIAL OFFICER $6.2M
89,586 sh across 8 lots
Exec Mar 27 2025
Filed Mar 31 2025 · 5:30 PM ET Meredith ManningSALE Chief Commercial Officer $2.9M
43,080 sh across 4 lots
Exec Mar 27 2025
Filed Mar 31 2025 · 5:30 PM ET Kristen YenSALE SEE REMARKS $6.3M
94,401 sh across 7 lots
Exec Mar 27 2025
Filed Mar 31 2025 · 5:30 PM ET Matthew PaulsSALE Director $425K
5,937 sh × $71.55
Exec Mar 28 2025
Filed Mar 31 2025 · 5:30 PM ET Vivo Opportunity Fund Holdings, L.P.SALE 10% owner $124.4M
1,833,557 sh across 3 lots
Exec Mar 26 2025
Filed Mar 28 2025 · 5:30 PM ET Bhatnagar AnishSALE CHIEF EXECUTIVE OFFICER $926K
20,231 sh across 2 lots
Exec Jan 2 2025
Filed Jan 6 2025 · 5:30 PM ET James H MackanessSALE CHIEF FINANCIAL OFFICER $346K
7,553 sh across 2 lots
Exec Jan 2 2025
Filed Jan 6 2025 · 5:30 PM ET Kristen YenSALE SEE REMARKS $213K
4,662 sh across 2 lots
Exec Jan 2 2025
Filed Jan 6 2025 · 5:30 PM ET Bhatnagar AnishSALE CHIEF EXECUTIVE OFFICER $1.1M
21,633 sh across 2 lots
Exec Oct 1 2024
Filed Oct 3 2024 · 5:30 PM ET Patricia C HiranoSALE SEE REMARKS $138K
2,789 sh × $49.34
Exec Oct 1 2024
Filed Oct 3 2024 · 5:30 PM ET James H MackanessSALE CHIEF FINANCIAL OFFICER $358K
7,248 sh × $49.34
Exec Oct 1 2024
Filed Oct 3 2024 · 5:30 PM ET Kristen YenSALE SEE REMARKS $138K
2,789 sh × $49.34
Exec Oct 1 2024
Filed Oct 3 2024 · 5:30 PM ET